Therefore, mGlu2/5-HT2A receptor heterocomplex mediated signaling cannot be ignored in the context of synergistic modulation of these two main neurotransmitter systems in the pathophysiology of depression and AD action of halucinogens. This evidence concerns the gene GRM2 and Alzheimer disease.